AFT Pharmaceuticals today announces it has signed licensing agreements for its Maxigesic pain relief medication in Germany, Pakistan and Vietnam, countries with pain relief markets worth more than US$1 billion.
New research from Monash University, in collaboration with the University of North Carolina, could change the way patients with life-threatening drug-resistant infections across the world are treated
‘The Godfather of Cannabis’, Professor Raphael Mechoulam, will play a key role in New Zealand’s first international medicinal cannabis summit, MedCan 2020 organisers have announced today
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) announces it expects to book a one-off non-cash gain of $9.8 million following its previously-announced acquisition of full control of its Pascomer assets
AbbVie (NYSE: ABBV) New Zealand welcomes PHARMAC’s announcement that patients with chronic lymphocytic leukaemia (CLL) whose cancer has relapsed within 36 months of previous treatment will now have funded access to VENCLEXTA® (venetoclax) in combination with rituximab, from 1 December 2019
This November, Diabetes NZ is teaming up with key organisations to help find the 100,000 Kiwis with undiagnosed type 2 diabetes. With the theme It’s About Time, Diabetes Action Month runs for all of November
The Pharmacy Guild of New Zealand (the Guild) welcomes the Government’s announcement that community pharmacists will now be able to deliver the MMR vaccine
Associate Minister of Health Julie Anne Genter says trained pharmacist vaccinators in approximately 450 pharmacies across New Zealand will soon be able to deliver MMR vaccinations to people aged 16 and over, as the latest step in the Government’s plan to stop the measles outbreak and improve the immunity of New Zealanders
Source
Media release from associate health minister Julie Anne Genter
